Search Results - Tiamiyu, Iyabode

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study

    Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study by Werth, Victoria P, Fleischmann, Roy, Robern, Michael, Touma, Zahi, Tiamiyu, Iyabode, Gurtovaya, Oksana, Pechonkina, Alena, Mozaffarian, Afsaneh, Downie, Bryan, Matzkies, Franziska, Wallace, Daniel

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    P128 A subgroup analysis of the efficacy of filgotinib for patients with moderately active RA following an inadequate response to methotrexate

    P128 A subgroup analysis of the efficacy of filgotinib for patients with moderately active RA following an inadequate response to methotrexate by Buch, Maya H, Walker, David, Kiely, Patrick D W, Edwards, Christopher J, Barry, Jane, McCaughey, Gerard, Akroyd, Laura, Tiamiyu, Iyabode, Ye, Lei, Chen, Kun, Taylor, Peter C

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: